Nivolumab Becomes First FDA-Approved Checkpoint Blockade for Kidney Cancer November 24, 2015December 14, 2022 Arthur N. Brodsky, PhD
First Monoclonal Antibody for Multiple Myeloma Receives FDA Approval November 20, 2015December 14, 2022 Alexandra Mulvey
Second Annual Immuno-Oncology 360° Conference November 17, 2015December 14, 2022 Arthur N. Brodsky, PhD
Making It Count: Team CRI Adds On Miles for Cancer Research November 5, 2015December 14, 2022 Jasmine Lingard
FDA Approves Immunotherapy to Help Prevent Relapse of Melanoma October 30, 2015December 14, 2022 Matthew Tontonoz